Tongluo Jiedu as an adjuvant therapy for oral cancer

doi:10.12998/wjcc.v13.i5.97909

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (346)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

222

Figures (1-1)

Sum=291

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=32

Feb 16, 2025 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Clin Cases. Feb 16, 2025; 13(5): 97909
Published online Feb 16, 2025. doi: 10.12998/wjcc.v13.i5.97909

Tongluo Jiedu as an adjuvant therapy for oral cancer

Sarah Monserrat Lomelí Martínez, Melissa Martínez Nieto, Ana Esther Mercado González

Sarah Monserrat Lomelí Martínez, Department of Medical and Life Sciences, Centro Universitario de la Ciénega, Universidad de Guadalajara, Ocotlán 47810, Mexico

Sarah Monserrat Lomelí Martínez, Department of Well-being and Sustainable Development, Centro Universitario del Norte, Universidad de Guadalajara, Colotlan 46200, Mexico

Melissa Martínez Nieto, Independent Researcher, Guadalajara 44340, Mexico

Ana Esther Mercado González, Antiguo Hospital Civil de Guadalajara “Fray Antonio Alcalde”, Universidad de Guadalajara, Guadalajara 44280, Mexico

Author contributions: All authors contributed equally to the preparation of this manuscript; Lomelí Martínez SM and Martínez Nieto M the idea; Lomelí Martínez SM, Martínez Nieto M and Mercado González AE did literature search and wrote the preliminary draft; Lomelí Martínez SM and Martínez Nieto M critically reviewed and approved the manuscript.

Conflict-of-interest statement: All the authors declare that they have no conflict of interest to disclose.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Sarah Monserrat Lomelí Martínez, PhD, Academic Research, Adjunct Associate Professor, Department of Medical and Life Sciences, Centro Universitario de la Ciénega, Universidad de Guadalajara, Av. Universidad 1115, Col. Lindavista, Ocotlán 47810, Mexico. sarah.lomeli@academicos.udg.mx

Received: June 12, 2024
Revised: October 11, 2024
Accepted: November 4, 2024
Published online: February 16, 2025
Processing time: 159 Days and 18.7 Hours

Core Tip

Core Tip: In this letter, we highlight the article by Yin et al recently published in the World Journal of Clinical Cases (2024), which was focused on the benefits of Tongluo Jiedu as an adjuvant treatment for oral cancer. The study showed that this treatment improved immune function and reduced oxidative stress, thereby aiding recovery of the oral cancer patients. We emphasize the need for early intervention, multidisciplinary management, and the potential of integrating traditional Chinese medicine with conventional therapies.